Artwork
iconShare
 
Manage episode 516920050 series 3698923
Content provided by CTI Clinical Trials. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by CTI Clinical Trials or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Alaa Assem, Managing Director for CTI in the Europe & MEA regions, joins us to discuss the evolution of clinical trials in the Middle East and Africa. With over a decade of experience in pharma and CROs, Alaa shares how CTI has built a strong regional presence, the impact of COVID-19, and why sponsors should consider the region for future trials.

Topics Covered:

Timestamps:

  • 00:00 – Meet Alaa and his background
  • 00:56 – CTI’s regional roots and growth
  • 02:19 – Why local presence matters
  • 03:20 – Clinical research evolution in the region
  • 05:02 – COVID-19’s transformative impact
  • 06:44 – Vaccine research and biotech hubs
  • 08:33 – Advice for sponsors entering the region
  • 10:33 – Changing perceptions and realities
  • 12:52 – CTI’s readiness and expansion strategy
  • 14:06 – Future growth and innovation
  • 15:42 – Alaa’s excitement for the future of research

  continue reading

35 episodes